| TNBC | Triple-Negative Breast Cancer |
| ER | Estrogen Receptor |
| PR | Progesterone receptor |
| HER2 | Human Epidermal Growth Factor Receptor 2 |
| DEGs | Differentially Expressed Genes |
| GO | Gene Ontology |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| BL | Basal-Like |
| PARP-1 | poly(ADP-ribose) polymerase-1 |
| EGFR | epidermal growth factor receptor |
| FGFR2 | fibroblast growth factor receptor 2 |
| VEGF | vascular endothelial growth factor |
| mTOR | the mammalian target of rapamycin |
| AMPK | 5′ adenosine monophosphate-activated protein kinase |
| PI3K | phosphatidylinositol-3-kinase |
| NGS | Next-Generation Sequencing |
| Dex | Dexamethasone |
| Log FC | log Fold Change |
| FDR | False Discovery Rate |
| BCV | Biological Coefficient of Variation |
| CPM | Counts per Million |
| AGE-RAG | Advanced glycation end products–Receptor for advanced glycation end products |
| Rap-1 | Ras-proximate-1 |
| SLC | solute carrier |
| BP | Biological Processes |
| CC | Cellular Components |
| MF | Molecular Function |
| TCA | Tricarboxylic acid cycle |
| DMSO | Dimethyl Sulphoxide |
| GEO | Gene Expression Omnibus |